MTOR and cancer: More PIK3CA/AKT1 mutations and PIK3CA copy gain are identified in ATC as compared to well differentiated cancer, suggesting that PI3K/mTOR pathway activity is involved in the process of cancer de-differentiation [3], [11], [12].